| Year |
Citation |
Score |
| 2015 |
Melnyk P, Vingtdeux V, Burlet S, Eddarkaoui S, Grosjean ME, Larchanché PE, Hochart G, Sergheraert C, Estrella C, Barrier M, Poix V, Plancq P, Lannoo C, Hamdane M, Delacourte A, et al. Chloroquine and chloroquinoline derivatives as models for the design of modulators of amyloid Peptide precursor metabolism. Acs Chemical Neuroscience. 6: 559-69. PMID 25611616 DOI: 10.1021/Cn5003013 |
0.403 |
|
| 2010 |
Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, Gauthier S, Hampel H, Jicha GA, Meguro K, O'Brien J, et al. Revising the definition of Alzheimer's disease: a new lexicon. The Lancet. Neurology. 9: 1118-27. PMID 20934914 DOI: 10.1016/S1474-4422(10)70223-4 |
0.429 |
|
| 2010 |
Hudry E, Van Dam D, Kulik W, De Deyn PP, Stet FS, Ahouansou O, Benraiss A, Delacourte A, Bougnères P, Aubourg P, Cartier N. Adeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after the onset of amyloid plaques in mouse models of Alzheimer's disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 44-53. PMID 19654569 DOI: 10.1038/Mt.2009.175 |
0.462 |
|
| 2009 |
Frisoni GB, Delacourte A. Neuroimaging outcomes in clinical trials in Alzheimer's disease. The Journal of Nutrition, Health & Aging. 13: 209-12. PMID 19262955 DOI: 10.1007/S12603-009-0060-7 |
0.35 |
|
| 2009 |
Caparros-Lefebvre D, Kerdraon O, Devos D, Dhaenens CM, Blum D, Maurage CA, Delacourte A, Sablonnière B. Association of corticobasal degeneration and Huntington's disease: can Tau aggregates protect Huntingtin toxicity? Movement Disorders : Official Journal of the Movement Disorder Society. 24: 1089-90. PMID 19243029 DOI: 10.1002/Mds.22204 |
0.429 |
|
| 2009 |
Rudinskiy N, Grishchuk Y, Vaslin A, Puyal J, Delacourte A, Hirling H, Clarke PG, Luthi-Carter R. Calpain hydrolysis of alpha- and beta2-adaptins decreases clathrin-dependent endocytosis and may promote neurodegeneration. The Journal of Biological Chemistry. 284: 12447-58. PMID 19240038 DOI: 10.1074/Jbc.M804740200 |
0.315 |
|
| 2009 |
Thathiah A, Spittaels K, Hoffmann M, Staes M, Cohen A, Horré K, Vanbrabant M, Coun F, Baekelandt V, Delacourte A, Fischer DF, Pollet D, De Strooper B, Merchiers P. The orphan G protein-coupled receptor 3 modulates amyloid-beta peptide generation in neurons. Science (New York, N.Y.). 323: 946-51. PMID 19213921 DOI: 10.1126/Science.1160649 |
0.434 |
|
| 2009 |
Hébert SS, Horré K, Nicolaï L, Bergmans B, Papadopoulou AS, Delacourte A, De Strooper B. MicroRNA regulation of Alzheimer's Amyloid precursor protein expression. Neurobiology of Disease. 33: 422-8. PMID 19110058 DOI: 10.1016/J.Nbd.2008.11.009 |
0.32 |
|
| 2009 |
Cartier N, Hudry E, Dam Dv, Kulik W, Deyn PPd, Delacourte A, Aubourg P. Enhanced conversion of cholesterol to 24s-hydroxycholesterol decreases amyloid-ß and prevents alzheimer phenotype of app23 mouse model Alzheimers & Dementia. 5: 138. DOI: 10.1016/J.Jalz.2009.05.469 |
0.39 |
|
| 2008 |
Delacourte A. Tau pathology and neurodegeneration: an obvious but misunderstood link. Journal of Alzheimer's Disease : Jad. 14: 437-40. PMID 18688095 DOI: 10.3233/Jad-2008-14412 |
0.483 |
|
| 2008 |
Delacourte A. Tau, a biological marker of neurodegenerative diseases. Handbook of Clinical Neurology. 89: 161-72. PMID 18631741 DOI: 10.1016/S0072-9752(07)01215-8 |
0.514 |
|
| 2008 |
Sergeant N, Bretteville A, Hamdane M, Caillet-Boudin ML, Grognet P, Bombois S, Blum D, Delacourte A, Pasquier F, Vanmechelen E, Schraen-Maschke S, Buée L. Biochemistry of Tau in Alzheimer's disease and related neurological disorders. Expert Review of Proteomics. 5: 207-24. PMID 18466052 DOI: 10.1586/14789450.5.2.207 |
0.471 |
|
| 2008 |
Hébert SS, Horré K, Nicolaï L, Papadopoulou AS, Mandemakers W, Silahtaroglu AN, Kauppinen S, Delacourte A, De Strooper B. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proceedings of the National Academy of Sciences of the United States of America. 105: 6415-20. PMID 18434550 DOI: 10.1073/Pnas.0710263105 |
0.399 |
|
| 2008 |
Kashani A, Lepicard E, Poirel O, Videau C, David JP, Fallet-Bianco C, Simon A, Delacourte A, Giros B, Epelbaum J, Betancur C, El Mestikawy S. Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease. Neurobiology of Aging. 29: 1619-30. PMID 17531353 DOI: 10.1016/J.Neurobiolaging.2007.04.010 |
0.4 |
|
| 2008 |
Deramecourt V, Bombois S, Mackowiak M, Delacourte A, Buee L, Maurage C, Lebert F, Pasquier F. P3-008: Associated cerebral lesions in Alzheimer's disease generate clinical diagnosis difficulties: An autopsy study Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.1571 |
0.36 |
|
| 2007 |
Boutillier S, Lannes B, Buée L, Delacourte A, Rouaux C, Mohr M, Bellocq JP, Sellal F, Larmet Y, Boutillier AL, Loeffler JP. Sp3 and sp4 transcription factor levels are increased in brains of patients with Alzheimer's disease. Neuro-Degenerative Diseases. 4: 413-23. PMID 17934324 DOI: 10.1159/000107701 |
0.399 |
|
| 2007 |
Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'brien J, Pasquier F, Robert P, Rossor M, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. The Lancet. Neurology. 6: 734-46. PMID 17616482 DOI: 10.1016/S1474-4422(07)70178-3 |
0.451 |
|
| 2007 |
Cacquevel M, Launay S, Castel H, Benchenane K, Chéenne S, Buée L, Moons L, Delacourte A, Carmeliet P, Vivien D. Ageing and amyloid-beta peptide deposition contribute to an impaired brain tissue plasminogen activator activity by different mechanisms. Neurobiology of Disease. 27: 164-73. PMID 17566751 DOI: 10.1016/J.Nbd.2007.04.004 |
0.392 |
|
| 2007 |
Evans TA, Raina AK, Delacourte A, Aprelikova O, Lee HG, Zhu X, Perry G, Smith MA. BRCA1 may modulate neuronal cell cycle re-entry in Alzheimer disease. International Journal of Medical Sciences. 4: 140-5. PMID 17505559 DOI: 10.7150/Ijms.4.140 |
0.371 |
|
| 2007 |
Ma H, Lesné S, Kotilinek L, Steidl-Nichols JV, Sherman M, Younkin L, Younkin S, Forster C, Sergeant N, Delacourte A, Vassar R, Citron M, Kofuji P, Boland LM, Ashe KH. Involvement of beta-site APP cleaving enzyme 1 (BACE1) in amyloid precursor protein-mediated enhancement of memory and activity-dependent synaptic plasticity. Proceedings of the National Academy of Sciences of the United States of America. 104: 8167-72. PMID 17470798 DOI: 10.1073/Pnas.0609521104 |
0.345 |
|
| 2007 |
Vingtdeux V, Hamdane M, Loyens A, Gelé P, Drobeck H, Bégard S, Galas MC, Delacourte A, Beauvillain JC, Buée L, Sergeant N. Alkalizing drugs induce accumulation of amyloid precursor protein by-products in luminal vesicles of multivesicular bodies. The Journal of Biological Chemistry. 282: 18197-205. PMID 17468104 DOI: 10.1074/Jbc.M609475200 |
0.391 |
|
| 2007 |
Bombois S, Maurage CA, Gompel M, Deramecourt V, Mackowiak-Cordoliani MA, Black RS, Lavielle R, Delacourte A, Pasquier F. Absence of beta-amyloid deposits after immunization in Alzheimer disease with Lewy body dementia. Archives of Neurology. 64: 583-7. PMID 17420322 DOI: 10.1001/Archneur.64.4.583 |
0.465 |
|
| 2007 |
Vingtdeux V, Hamdane M, Bégard S, Loyens A, Delacourte A, Beauvillain JC, Buée L, Marambaud P, Sergeant N. Intracellular pH regulates amyloid precursor protein intracellular domain accumulation. Neurobiology of Disease. 25: 686-96. PMID 17207630 DOI: 10.1016/J.Nbd.2006.09.019 |
0.41 |
|
| 2006 |
Delacourte A. The natural and molecular history of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 9: 187-94. PMID 16914858 DOI: 10.3233/Jad-2006-9S322 |
0.49 |
|
| 2006 |
Leroy O, Dhaenens CM, Schraen-Maschke S, Belarbi K, Delacourte A, Andreadis A, Sablonnière B, Buée L, Sergeant N, Caillet-Boudin ML. ETR-3 represses Tau exons 2/3 inclusion, a splicing event abnormally enhanced in myotonic dystrophy type I. Journal of Neuroscience Research. 84: 852-9. PMID 16862542 DOI: 10.1002/Jnr.20980 |
0.364 |
|
| 2006 |
Hamdane M, Dourlen P, Bretteville A, Sambo AV, Ferreira S, Ando K, Kerdraon O, Bégard S, Geay L, Lippens G, Sergeant N, Delacourte A, Maurage CA, Galas MC, Buée L. Pin1 allows for differential Tau dephosphorylation in neuronal cells. Molecular and Cellular Neurosciences. 32: 155-60. PMID 16697218 DOI: 10.1016/J.Mcn.2006.03.006 |
0.451 |
|
| 2006 |
Deramecourt V, Bombois S, Maurage CA, Ghestem A, Drobecq H, Vanmechelen E, Lebert F, Pasquier F, Delacourte A. Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies. Journal of Neuropathology and Experimental Neurology. 65: 278-88. PMID 16651889 DOI: 10.1097/01.Jnen.0000205145.54457.Ea |
0.481 |
|
| 2006 |
Husson M, Enderlin V, Delacourte A, Ghenimi N, Alfos S, Pallet V, Higueret P. Retinoic acid normalizes nuclear receptor mediated hypo-expression of proteins involved in beta-amyloid deposits in the cerebral cortex of vitamin A deprived rats. Neurobiology of Disease. 23: 1-10. PMID 16531051 DOI: 10.1016/J.Nbd.2006.01.008 |
0.364 |
|
| 2006 |
Schraen-Maschke S, Crinquette C, Bombois S, Delacourte A, Buee L, Sablonniere B, Pasquier F. P2-133: Determination of tau, phospho-tau and Abeta1-42 levels in cerebrospinal fluid of patients as a help for the early diagnosis of AD: The french experience in lille Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.971 |
0.44 |
|
| 2006 |
Deramecourt V, Bombois S, Maurage C, Lebert F, Delacourte A, Pasquier F. P4-113: Clinicopathologic and biochemical overlap of frontotemporal degeneration, corticobasal degeneration and progressive supranuclear palsy: The Lille-Bailleul French cohort Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.1852 |
0.303 |
|
| 2006 |
Vanmechelen E, Vandecasteele L, Grognet P, Catry C, Ghestem A, Gompel M, Decraemer H, Callebaut P, Kerschaver EV, Vanderstichele H, Sergeant N, Buee L, Kostanjevecki V, Blennow K, Delacourte A. P3-090: Potential diagnostic relevance of amino-terminally truncated beta-amyloid species in sporadic Alzheimer’s disease: A prospective brain study Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.1357 |
0.364 |
|
| 2005 |
Maurage CA, Udd B, Ruchoux MM, Vermersch P, Kalimo H, Krahe R, Delacourte A, Sergeant N. Similar brain tau pathology in DM2/PROMM and DM1/Steinert disease. Neurology. 65: 1636-8. PMID 16301494 DOI: 10.1212/01.Wnl.0000184585.93864.4E |
0.42 |
|
| 2005 |
Vingtdeux V, Hamdane M, Gompel M, Bégard S, Drobecq H, Ghestem A, Grosjean ME, Kostanjevecki V, Grognet P, Vanmechelen E, Buée L, Delacourte A, Sergeant N. Phosphorylation of amyloid precursor carboxy-terminal fragments enhances their processing by a gamma-secretase-dependent mechanism. Neurobiology of Disease. 20: 625-37. PMID 15936948 DOI: 10.1016/J.Nbd.2005.05.004 |
0.408 |
|
| 2005 |
Santiard-Baron D, Langui D, Delehedde M, Delatour B, Schombert B, Touchet N, Tremp G, Paul MF, Blanchard V, Sergeant N, Delacourte A, Duyckaerts C, Pradier L, Mercken L. Expression of human FE65 in amyloid precursor protein transgenic mice is associated with a reduction in beta-amyloid load. Journal of Neurochemistry. 93: 330-8. PMID 15816856 DOI: 10.1111/J.1471-4159.2005.03026.X |
0.356 |
|
| 2005 |
Lain E, Penke B, Delacourte A, Gündisch D, Schröder H, Witter B. Effects of Abeta1-42 fibrils and of the tetrapeptide Pr-IIGL on the phosphorylation state of the tau-protein and on the alpha7 nicotinic acetylcholine receptor in vitro. The European Journal of Neuroscience. 21: 879-88. PMID 15787694 DOI: 10.1111/J.1460-9568.2005.03909.X |
0.412 |
|
| 2005 |
Hamdane M, Bretteville A, Sambo AV, Schindowski K, Bégard S, Delacourte A, Bertrand P, Buée L. p25/Cdk5-mediated retinoblastoma phosphorylation is an early event in neuronal cell death. Journal of Cell Science. 118: 1291-8. PMID 15741232 DOI: 10.1242/Jcs.01724 |
0.303 |
|
| 2005 |
Delobel P, Leroy O, Hamdane M, Sambo AV, Delacourte A, Buée L. Proteasome inhibition and Tau proteolysis: an unexpected regulation. Febs Letters. 579: 1-5. PMID 15620682 DOI: 10.1016/J.Febslet.2004.11.018 |
0.516 |
|
| 2005 |
Sergeant N, Delacourte A, Buée L. Tau protein as a differential biomarker of tauopathies. Biochimica Et Biophysica Acta. 1739: 179-97. PMID 15615637 DOI: 10.1016/J.Bbadis.2004.06.020 |
0.536 |
|
| 2005 |
Vanmechelen E, Grognet P, Vandecasteele L, Sergeant N, Ghestem A, Decraemer H, Catry C, Demeyer L, Callebaut P, Gompel M, Olsson A, Vanderstichele H, Kostanjevecki V, Blennow K, Delacourte A. S1-6 Perspectives on potential biomarkers in blood for Alzheimer diagnosis Revue Neurologique. 161: 25-26. DOI: 10.1016/S0035-3787(05)85250-6 |
0.34 |
|
| 2004 |
Abad-Rodriguez J, Ledesma MD, Craessaerts K, Perga S, Medina M, Delacourte A, Dingwall C, De Strooper B, Dotti CG. Neuronal membrane cholesterol loss enhances amyloid peptide generation. The Journal of Cell Biology. 167: 953-60. PMID 15583033 DOI: 10.1083/Jcb.200404149 |
0.385 |
|
| 2004 |
Maurage CA, Bussière T, Sergeant N, Ghesteem A, Figarella-Branger D, Ruchoux MM, Pellissier JF, Delacourte A. Tau aggregates are abnormally phosphorylated in inclusion body myositis and have an immunoelectrophoretic profile distinct from other tauopathies. Neuropathology and Applied Neurobiology. 30: 624-34. PMID 15541003 DOI: 10.1111/J.1365-2990.2004.00577.X |
0.49 |
|
| 2004 |
Casas C, Sergeant N, Itier JM, Blanchard V, Wirths O, van der Kolk N, Vingtdeux V, van de Steeg E, Ret G, Canton T, Drobecq H, Clark A, Bonici B, Delacourte A, Benavides J, et al. Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model. The American Journal of Pathology. 165: 1289-300. PMID 15466394 DOI: 10.1016/S0002-9440(10)63388-3 |
0.436 |
|
| 2004 |
Guevara J, Dilhuydy H, Espinosa B, Delacourte A, Quirion R, Mena R, Joanette Y, Zenteno E, Robitaille Y. Coexistence of reactive plasticity and neurodegeneration in Alzheimer diseased brains. Histology and Histopathology. 19: 1075-84. PMID 15375749 DOI: 10.14670/HH-19.1075 |
0.386 |
|
| 2004 |
Dhaenens CM, Van Brussel E, Schraen-Maschke S, Pasquier F, Delacourte A, Sablonnière B. Association study of three polymorphisms of kinesin light-chain 1 gene with Alzheimer's disease. Neuroscience Letters. 368: 290-2. PMID 15364413 DOI: 10.1016/J.Neulet.2004.07.040 |
0.372 |
|
| 2004 |
Funalot B, Ouimet T, Claperon A, Fallet C, Delacourte A, Epelbaum J, Subkowski T, Léonard N, Codron V, David JP, Amouyel P, Schwartz JC, Helbecque N. Endothelin-converting enzyme-1 is expressed in human cerebral cortex and protects against Alzheimer's disease. Molecular Psychiatry. 9: 1122-8, 1059. PMID 15340356 DOI: 10.1038/Sj.Mp.4001584 |
0.407 |
|
| 2004 |
Borghi R, Piccini A, Delacourte A, Strocchi P, Zaccheo D, Tabaton M. Protein levels of glycogen synthase 3 kinase are normal in progressive supranuclear palsy. Neuroscience Letters. 366: 67-70. PMID 15265592 DOI: 10.1016/J.Neulet.2004.05.014 |
0.399 |
|
| 2004 |
Soulié C, Nicole A, Delacourte A, Ceballos-Picot I. Examination of stress-related genes in human temporal versus occipital cortex in the course of neurodegeneration: involvement of 14-3-3 zeta in this dynamic process. Neuroscience Letters. 365: 1-5. PMID 15234461 DOI: 10.1016/J.Neulet.2004.03.090 |
0.348 |
|
| 2004 |
Le Ber I, Martinez M, Campion D, Laquerrière A, Bétard C, Bassez G, Girard C, Saugier-Veber P, Raux G, Sergeant N, Magnier P, Maisonobe T, Eymard B, Duyckaerts C, Delacourte A, et al. A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24. Brain : a Journal of Neurology. 127: 1979-92. PMID 15215218 DOI: 10.1093/Brain/Awh216 |
0.402 |
|
| 2004 |
Schraen-Maschke S, Dhaenens CM, Delacourte A, Sablonnière B. Microtubule-associated protein tau gene: a risk factor in human neurodegenerative diseases. Neurobiology of Disease. 15: 449-60. PMID 15056452 DOI: 10.1016/J.Nbd.2003.12.009 |
0.493 |
|
| 2004 |
Kostanjevecki V, Degrieck R, Debrabandere V, Vanderstichele H, Sergeant N, Bosmans F, Delacourte A, Blennow K, Vanmechelen E. P3-031 A novel β-amyloid42 index in cerebrospinal fluid for specific determination of Alzheimer's disease Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)81185-0 |
0.395 |
|
| 2004 |
Maurage CA, Sambo AV, Hamdame M, Ruchoux MM, Delacourte A, Buée L. Pin1, marqueur précoce de l’agrégation des protéines tau Revue Neurologique. 160: 846. DOI: 10.1016/S0035-3787(04)71046-2 |
0.43 |
|
| 2003 |
Delobel P, Mailliot C, Hamdane M, Sambo AV, Bégard S, Violleau A, Delacourte A, Buée L. Stable-tau overexpression in human neuroblastoma cells: an open door for explaining neuronal death in tauopathies. Annals of the New York Academy of Sciences. 1010: 623-34. PMID 15033802 DOI: 10.1196/Annals.1299.115 |
0.461 |
|
| 2003 |
Delacourte A, Sergeant N, Buée L. In vitro models of age-related neurodegenerative disorders. Experimental Gerontology. 38: 1309-17. PMID 14698810 DOI: 10.1016/J.Exger.2003.09.010 |
0.466 |
|
| 2003 |
Ledesma MD, Abad-Rodriguez J, Galvan C, Biondi E, Navarro P, Delacourte A, Dingwall C, Dotti CG. Raft disorganization leads to reduced plasmin activity in Alzheimer's disease brains. Embo Reports. 4: 1190-6. PMID 14618158 DOI: 10.1038/Sj.Embor.7400021 |
0.398 |
|
| 2003 |
Winsky-Sommerer R, Grouselle D, Rougeot C, Laurent V, David JP, Delacourte A, Dournaud P, Seidah NG, Lindberg I, Trottier S, Epelbaum J. The proprotein convertase PC2 is involved in the maturation of prosomatostatin to somatostatin-14 but not in the somatostatin deficit in Alzheimer's disease. Neuroscience. 122: 437-47. PMID 14614908 DOI: 10.1016/S0306-4522(03)00560-8 |
0.445 |
|
| 2003 |
Hamdane M, Delobel P, Sambo AV, Smet C, Bégard S, Violleau A, Landrieu I, Delacourte A, Lippens G, Flament S, Buée L. Neurofibrillary degeneration of the Alzheimer-type: an alternate pathway to neuronal apoptosis? Biochemical Pharmacology. 66: 1619-25. PMID 14555242 DOI: 10.1016/S0006-2952(03)00533-1 |
0.394 |
|
| 2003 |
Maurage CA, Sergeant N, Schraen-Maschke S, Lebert F, Ruchoux MM, Sablonnière B, Pasquier F, Delacourte A. Diffuse form of argyrophilic grain disease: a new variant of four-repeat tauopathy different from limbic argyrophilic grain disease. Acta Neuropathologica. 106: 575-83. PMID 14517683 DOI: 10.1007/S00401-003-0762-6 |
0.442 |
|
| 2003 |
Munoz DG, Dickson DW, Bergeron C, Mackenzie IR, Delacourte A, Zhukareva V. The neuropathology and biochemistry of frontotemporal dementia. Annals of Neurology. 54: S24-8. PMID 12833365 DOI: 10.1002/Ana.10571 |
0.383 |
|
| 2003 |
Hamdane M, Sambo AV, Delobel P, Bégard S, Violleau A, Delacourte A, Bertrand P, Benavides J, Buée L. Mitotic-like tau phosphorylation by p25-Cdk5 kinase complex. The Journal of Biological Chemistry. 278: 34026-34. PMID 12826674 DOI: 10.1074/Jbc.M302872200 |
0.464 |
|
| 2003 |
Sergeant N, Bombois S, Ghestem A, Drobecq H, Kostanjevecki V, Missiaen C, Wattez A, David JP, Vanmechelen E, Sergheraert C, Delacourte A. Truncated beta-amyloid peptide species in pre-clinical Alzheimer's disease as new targets for the vaccination approach. Journal of Neurochemistry. 85: 1581-91. PMID 12787077 DOI: 10.1046/J.1471-4159.2003.01818.X |
0.427 |
|
| 2003 |
Royall DR, Román GC, Delacourte A. Pathological determinants of dementia in Alzheimer's disease (AD). Experimental Aging Research. 29: 107-10. PMID 12735084 DOI: 10.1080/03610730303707 |
0.477 |
|
| 2003 |
Weill-Engerer S, David JP, Sazdovitch V, Liere P, Schumacher M, Delacourte A, Baulieu EE, Akwa Y. In vitro metabolism of dehydroepiandrosterone (DHEA) to 7alpha-hydroxy-DHEA and Delta5-androstene-3beta,17beta-diol in specific regions of the aging brain from Alzheimer's and non-demented patients. Brain Research. 969: 117-25. PMID 12676372 DOI: 10.1016/S0006-8993(03)02288-1 |
0.305 |
|
| 2003 |
Lesné S, Docagne F, Gabriel C, Liot G, Lahiri DK, Buée L, Plawinski L, Delacourte A, MacKenzie ET, Buisson A, Vivien D. Transforming growth factor-beta 1 potentiates amyloid-beta generation in astrocytes and in transgenic mice. The Journal of Biological Chemistry. 278: 18408-18. PMID 12626500 DOI: 10.1074/Jbc.M300819200 |
0.326 |
|
| 2003 |
Sergeant N, Wattez A, Galván-valencia M, Ghestem A, David JP, Lemoine J, Sautiére PE, Dachary J, Mazat JP, Michalski JC, Velours J, Mena-López R, Delacourte A. Association of ATP synthase alpha-chain with neurofibrillary degeneration in Alzheimer's disease. Neuroscience. 117: 293-303. PMID 12614671 DOI: 10.1016/S0306-4522(02)00747-9 |
0.458 |
|
| 2003 |
Maurage CA, Sergeant N, Ruchoux MM, Hauw JJ, Delacourte A. Phosphorylated serine 199 of microtubule-associated protein tau is a neuronal epitope abundantly expressed in youth and an early marker of tau pathology. Acta Neuropathologica. 105: 89-97. PMID 12536218 DOI: 10.1007/S00401-002-0608-7 |
0.527 |
|
| 2003 |
Lefebvre T, Ferreira S, Dupont-Wallois L, Bussière T, Dupire MJ, Delacourte A, Michalski JC, Caillet-Boudin ML. Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins--a role in nuclear localization. Biochimica Et Biophysica Acta. 1619: 167-76. PMID 12527113 DOI: 10.1016/S0304-4165(02)00477-4 |
0.383 |
|
| 2003 |
Funalot B, Ouimet T, Claperon A, Fallet C, Delacourte A, Epelbaum J, Subkowski T, David JP, Amouyel P, Schwartz J-, Helbecque N. S.04.08 Expression of endothelin-converting enzyme-1 in human cerebral cortex protects against Alzheimer's disease European Neuropsychopharmacology. 13. DOI: 10.1016/S0924-977X(03)91616-6 |
0.342 |
|
| 2002 |
Hamdane M, Smet C, Sambo AV, Leroy A, Wieruszeski JM, Delobel P, Maurage CA, Ghestem A, Wintjens R, Bégard S, Sergeant N, Delacourte A, Horvath D, Landrieu I, Lippens G, et al. Pin1: a therapeutic target in Alzheimer neurodegeneration. Journal of Molecular Neuroscience : Mn. 19: 275-87. PMID 12540053 DOI: 10.1385/Jmn:19:3:275 |
0.447 |
|
| 2002 |
Delacourte A, Sergeant N, Wattez A, Maurage CA, Lebert F, Pasquier F, David JP. Tau aggregation in the hippocampal formation: an ageing or a pathological process? Experimental Gerontology. 37: 1291-6. PMID 12470843 DOI: 10.1016/S0531-5565(02)00141-9 |
0.477 |
|
| 2002 |
Delobel P, Flament S, Hamdane M, Mailliot C, Sambo AV, Bégard S, Sergeant N, Delacourte A, Vilain JP, Buée L. Abnormal Tau phosphorylation of the Alzheimer-type also occurs during mitosis. Journal of Neurochemistry. 83: 412-20. PMID 12423251 DOI: 10.1046/J.1471-4159.2002.01143.X |
0.462 |
|
| 2002 |
Weill-Engerer S, David JP, Sazdovitch V, Liere P, Eychenne B, Pianos A, Schumacher M, Delacourte A, Baulieu EE, Akwa Y. Neurosteroid quantification in human brain regions: comparison between Alzheimer's and nondemented patients. The Journal of Clinical Endocrinology and Metabolism. 87: 5138-43. PMID 12414884 DOI: 10.1210/Jc.2002-020878 |
0.416 |
|
| 2002 |
Tolnay M, Sergeant N, Ghestem A, Chalbot S, De Vos RA, Jansen Steur EN, Probst A, Delacourte A. Argyrophilic grain disease and Alzheimer's disease are distinguished by their different distribution of tau protein isoforms. Acta Neuropathologica. 104: 425-34. PMID 12200631 DOI: 10.1007/S00401-002-0591-Z |
0.539 |
|
| 2002 |
Delacourte A, Sergeant N, Champain D, Wattez A, Maurage CA, Lebert F, Pasquier F, David JP. Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer's disease. Neurology. 59: 398-407. PMID 12177374 DOI: 10.1212/Wnl.59.3.398 |
0.515 |
|
| 2002 |
Buée L, Hamdane M, Delobel P, Sambo AV, Bégard S, Ghestem A, Sergeant N, Delacourte A. [Tau story: from frontotemporal dementia to other tauopathies]. Journal De La Sociã©Tã© De Biologie. 196: 103-8. PMID 12134624 |
0.413 |
|
| 2002 |
Sergeant N, David JP, Champain D, Ghestem A, Wattez A, Delacourte A. Progressive decrease of amyloid precursor protein carboxy terminal fragments (APP-CTFs), associated with tau pathology stages, in Alzheimer's disease. Journal of Neurochemistry. 81: 663-72. PMID 12065626 DOI: 10.1046/J.1471-4159.2002.00901.X |
0.519 |
|
| 2002 |
Delobel P, Flament S, Hamdane M, Delacourte A, Vilain JP, Buée L. Modelling Alzheimer-specific abnormal Tau phosphorylation independently of GSK3beta and PKA kinase activities. Febs Letters. 516: 151-5. PMID 11959122 DOI: 10.1016/S0014-5793(02)02525-5 |
0.453 |
|
| 2002 |
Royall DR, Palmer R, Mulroy AR, Polk MJ, Román GC, David JP, Delacourte A. Pathological determinants of the transition to clinical dementia in Alzheimer's disease. Experimental Aging Research. 28: 143-62. PMID 11928525 DOI: 10.1080/03610730252800166 |
0.376 |
|
| 2002 |
Caparros-Lefebvre D, Sergeant N, Lees A, Camuzat A, Daniel S, Lannuzel A, Brice A, Tolosa E, Delacourte A, Duyckaerts C. Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy. Brain : a Journal of Neurology. 125: 801-11. PMID 11912113 DOI: 10.1093/Brain/Awf086 |
0.397 |
|
| 2002 |
Borghi R, Giliberto L, Assini A, Delacourte A, Perry G, Smith MA, Strocchi P, Zaccheo D, Tabaton M. Increase of cdk5 is related to neurofibrillary pathology in progressive supranuclear palsy. Neurology. 58: 589-92. PMID 11865137 DOI: 10.1212/Wnl.58.4.589 |
0.501 |
|
| 2002 |
Delobel P, Flament S, Hamdane M, Jakes R, Rousseau A, Delacourte A, Vilain JP, Goedert M, Buée L. Functional characterization of FTDP-17 tau gene mutations through their effects on Xenopus oocyte maturation. The Journal of Biological Chemistry. 277: 9199-205. PMID 11756436 DOI: 10.1074/Jbc.M107716200 |
0.404 |
|
| 2002 |
Buée L, Delacourte A. La maladie d’Alzheimer : une tauopathie parmi d’autres ? M S-Medecine Sciences. 18: 727-736. DOI: 10.1051/Medsci/20021867727 |
0.303 |
|
| 2002 |
Buée L, Hamdane M, Delobel P, Sambo A, Bégard S, Ghestem A, Sergeant N, Delacourte A. Tau story : des démences fronto-temporales aux autres tauopathies Biologie Aujourd'Hui. 196: 103-108. DOI: 10.1051/Jbio/2002196010103 |
0.363 |
|
| 2001 |
Galván M, David JP, Delacourte A, Luna J, Mena R. Sequence of neurofibrillary changes in aging and Alzheimer's disease: A confocal study with phospho-tau antibody, AD2. Journal of Alzheimer's Disease : Jad. 3: 417-425. PMID 12214046 DOI: 10.3233/Jad-2001-3409 |
0.488 |
|
| 2001 |
Seznec H, Agbulut O, Sergeant N, Savouret C, Ghestem A, Tabti N, Willer JC, Ourth L, Duros C, Brisson E, Fouquet C, Butler-Browne G, Delacourte A, Junien C, Gourdon G. Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities. Human Molecular Genetics. 10: 2717-26. PMID 11726559 DOI: 10.1093/Hmg/10.23.2717 |
0.316 |
|
| 2001 |
Maurage CA, Sergeant N, Ruchoux MM, Hauw JJ, Delacourte A. Paradoxical phosphorylation of the serine 199 on tau proteins from young individuals. Neuroreport. 12: 3177-81. PMID 11711851 DOI: 10.1097/00001756-200110290-00007 |
0.455 |
|
| 2001 |
Sergeant N, Sablonnière B, Schraen-Maschke S, Ghestem A, Maurage CA, Wattez A, Vermersch P, Delacourte A. Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1. Human Molecular Genetics. 10: 2143-55. PMID 11590131 DOI: 10.1093/Hmg/10.19.2143 |
0.487 |
|
| 2001 |
Riederer BM, Mourton-Gilles C, Frey P, Delacourte A, Probst A. Differential phosphorylation of tau proteins during kitten brain development and Alzheimer's disease. Journal of Neurocytology. 30: 145-58. PMID 11577253 DOI: 10.1023/A:1011991207942 |
0.527 |
|
| 2001 |
Delacourte A. The molecular parameters of tau pathology. Tau as a killer and a witness. Advances in Experimental Medicine and Biology. 487: 5-19. PMID 11403165 DOI: 10.1007/978-1-4615-1249-3_2 |
0.517 |
|
| 2001 |
Guise S, Braguer D, Carles G, Delacourte A, Briand C. Hyperphosphorylation of tau is mediated by ERK activation during anticancer drug-induced apoptosis in neuroblastoma cells. Journal of Neuroscience Research. 63: 257-67. PMID 11170175 DOI: 10.1002/1097-4547(20010201)63:3<257::Aid-Jnr1019>3.0.Co;2-T |
0.424 |
|
| 2001 |
Buée L, Delacourte A, Wilhelmsen KC, Miller B, Geschwind D. Neuronal subpopulations and genetic background in tauopathies: a catch 22 story? Neurobiology of Aging. 22: 115-21. PMID 11164283 DOI: 10.1016/S0197-4580(00)00199-8 |
0.413 |
|
| 2000 |
Ledesma MD, Da Silva JS, Crassaerts K, Delacourte A, De Strooper B, Dotti CG. Brain plasmin enhances APP alpha-cleavage and Abeta degradation and is reduced in Alzheimer's disease brains. Embo Reports. 1: 530-5. PMID 11263499 DOI: 10.1093/Embo-Reports/Kvd107 |
0.47 |
|
| 2000 |
Mailliot C, Bussière T, Hamdane M, Sergeant N, Caillet ML, Delacourte A, Buée L. Pathological tau phenotypes. The weight of mutations, polymorphisms, and differential neuronal vulnerabilities. Annals of the New York Academy of Sciences. 920: 107-14. PMID 11193138 DOI: 10.1111/J.1749-6632.2000.Tb06911.X |
0.482 |
|
| 2000 |
Ferreira S, Dupire MJ, Delacourte A, Najib J, Caillet-Boudin ML. Synthesis and regulation of apolipoprotein E during the differentiation of human neuronal precursor NT2/D1 cells into postmitotic neurons. Experimental Neurology. 166: 415-21. PMID 11085906 DOI: 10.1006/Exnr.2000.7510 |
0.311 |
|
| 2000 |
Delacourte A, Buée L. Tau pathology: a marker of neurodegenerative disorders. Current Opinion in Neurology. 13: 371-6. PMID 10970052 DOI: 10.1097/00019052-200008000-00002 |
0.483 |
|
| 2000 |
Buée L, Bussière T, Buée-Scherrer V, Delacourte A, Hof PR. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Research. Brain Research Reviews. 33: 95-130. PMID 10967355 DOI: 10.1016/S0165-0173(00)00019-9 |
0.499 |
|
| 2000 |
Ishizawa K, Ksiezak-Reding H, Davies P, Delacourte A, Tiseo P, Yen SH, Dickson DW. A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy and Pick's disease. Acta Neuropathologica. 100: 235-44. PMID 10965792 DOI: 10.1007/S004019900177 |
0.519 |
|
| 2000 |
Mailliot C, Podevin-Dimster V, Rosenthal RE, Sergeant N, Delacourte A, Fiskum G, Buée L. Rapid tau protein dephosphorylation and differential rephosphorylation during cardiac arrest-induced cerebral ischemia and reperfusion. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 20: 543-9. PMID 10724119 DOI: 10.1097/00004647-200003000-00013 |
0.413 |
|
| 2000 |
Delacourte A, Wattez A, Sergeant N. Neurofibrillary Degeneration: Patterns of Tau Isoform Expression Neurobiology of Aging. 21: 210. DOI: 10.1016/S0197-4580(00)83272-8 |
0.377 |
|
| 1999 |
Buée L, Delacourte A. Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease. Brain Pathology (Zurich, Switzerland). 9: 681-93. PMID 10517507 DOI: 10.1111/J.1750-3639.1999.Tb00550.X |
0.507 |
|
| 1999 |
Delacourte A. Biochemical and molecular characterization of neurofibrillary degeneration in frontotemporal dementias. Dementia and Geriatric Cognitive Disorders. 10: 75-9. PMID 10436346 DOI: 10.1159/000051218 |
0.464 |
|
| 1999 |
Pérez-Tur J, Buée L, Morris HR, Waring SC, Onstead L, Wavrant-De Vrièze F, Crook R, Buée-Scherrer V, Hof PR, Petersen RC, McGeer PL, Delacourte A, Hutton M, Siddique T, Ahlskog JE, et al. Neurodegenerative diseases of Guam: analysis of TAU. Neurology. 53: 411-3. PMID 10430438 DOI: 10.1212/Wnl.53.2.411 |
0.42 |
|
| 1999 |
Sato N, Hori O, Yamaguchi A, Lambert JC, Chartier-Harlin MC, Robinson PA, Delacourte A, Schmidt AM, Furuyama T, Imaizumi K, Tohyama M, Takagi T. A novel presenilin-2 splice variant in human Alzheimer's disease brain tissue. Journal of Neurochemistry. 72: 2498-505. PMID 10349860 DOI: 10.1046/J.1471-4159.1999.0722498.X |
0.407 |
|
| 1999 |
Delacourte A, David JP, Sergeant N, Buée L, Wattez A, Vermersch P, Ghozali F, Fallet-Bianco C, Pasquier F, Lebert F, Petit H, Di Menza C. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology. 52: 1158-65. PMID 10214737 DOI: 10.1212/Wnl.52.6.1158 |
0.445 |
|
| 1999 |
Bussière T, Hof PR, Mailliot C, Brown CD, Caillet-Boudin ML, Perl DP, Buée L, Delacourte A. Phosphorylated serine422 on tau proteins is a pathological epitope found in several diseases with neurofibrillary degeneration. Acta Neuropathologica. 97: 221-30. PMID 10090668 DOI: 10.1007/S004010050978 |
0.542 |
|
| 1999 |
Sergeant N, Wattez A, Delacourte A. Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively "exon 10" isoforms. Journal of Neurochemistry. 72: 1243-9. PMID 10037497 DOI: 10.1046/J.1471-4159.1999.0721243.X |
0.527 |
|
| 1998 |
Pasquier F, Delacourte A. Non-Alzheimer degenerative dementias. Current Opinion in Neurology. 11: 417-27. PMID 9847989 DOI: 10.1097/00019052-199408000-00005 |
0.439 |
|
| 1998 |
Grouselle D, Winsky-Sommerer R, David JP, Delacourte A, Dournaud P, Epelbaum J. Loss of somatostatin-like immunoreactivity in the frontal cortex of Alzheimer patients carrying the apolipoprotein epsilon 4 allele. Neuroscience Letters. 255: 21-4. PMID 9839717 DOI: 10.1016/S0304-3940(98)00698-3 |
0.397 |
|
| 1998 |
Mailliot C, Bussière T, Caillet-Boudin ML, Delacourte A, Buée L. Alzheimer-specific epitope of AT100 in transfected cell lines with tau: toward an efficient cell model of tau abnormal phosphorylation. Neuroscience Letters. 255: 13-6. PMID 9839715 DOI: 10.1016/S0304-3940(98)00693-4 |
0.453 |
|
| 1998 |
Delacourte A. [Diagnosis of Alzheimer's disease]. Annales De Biologie Clinique. 56: 133-42. PMID 9754238 |
0.303 |
|
| 1998 |
Mailliot C, Sergeant N, Bussière T, Caillet-Boudin ML, Delacourte A, Buée L. Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes. Febs Letters. 433: 201-4. PMID 9744794 DOI: 10.1016/S0014-5793(98)00910-7 |
0.527 |
|
| 1998 |
Lambert JC, Berr C, Pasquier F, Delacourte A, Frigard B, Cottel D, Pérez-Tur J, Mouroux V, Mohr M, Cécyre D, Galasko D, Lendon C, Poirier J, Hardy J, Mann D, et al. Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease. Human Molecular Genetics. 7: 1511-6. PMID 9700208 DOI: 10.1093/Hmg/7.9.1511 |
0.346 |
|
| 1998 |
Caillet-Boudin ML, Dupont-Wallois L, Soulié C, Delacourte A. Apolipoprotein E and Tau phosphorylation in human neuroblastoma cells. Neuroscience Letters. 250: 83-6. PMID 9697924 DOI: 10.1016/S0304-3940(98)00448-0 |
0.424 |
|
| 1998 |
Davies P, Resnick J, Resnick B, Gilman S, Growdon JH, Khachaturian ZS, Radebaugh TS, Roses AD, Selkoe DJ, Trojanowski JQ, Blass JP, Gibson GE, Sheu KFR, Blennow K, Delacourte A, et al. Consensus report of the working group on: 'Molecular and biochemical markers of Alzheimer's disease' Neurobiology of Aging. 19: 109-116. PMID 9558143 DOI: 10.1016/S0197-4580(98)00022-0 |
0.463 |
|
| 1998 |
Delacourte A, Sergeant N, Wattez A, Gauvreau D, Robitaille Y. Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their tau isoform distribution and phosphorylation. Annals of Neurology. 43: 193-204. PMID 9485060 DOI: 10.1002/Ana.410430209 |
0.541 |
|
| 1998 |
Delacourte A, Buée L, David JP, Sergeant N, Wattez A, Vermersch P, Pasquier F, Lebert F, Ghozali F, Fallet-Bianco C, Di Menza C. Lack of continuum between cerebral aging and Alzheimer's disease as revealed by PHF-tau and Aβ biochemistry Alzheimer's Reports. 1: 101-110. |
0.405 |
|
| 1997 |
Dupont-Wallois L, Soulié C, Sergeant N, Wavrant-de Wrieze N, Chartier-Harlin MC, Delacourte A, Caillet-Boudin ML. ApoE synthesis in human neuroblastoma cells. Neurobiology of Disease. 4: 356-64. PMID 9440124 DOI: 10.1006/Nbdi.1997.0155 |
0.398 |
|
| 1997 |
David JP, Ghozali F, Fallet-Bianco C, Wattez A, Delaine S, Boniface B, Di Menza C, Delacourte A. Glial reaction in the hippocampal formation is highly correlated with aging in human brain. Neuroscience Letters. 235: 53-6. PMID 9389594 DOI: 10.1016/S0304-3940(97)00708-8 |
0.322 |
|
| 1997 |
Buée L, Hof PR, Delacourte A. Brain microvascular changes in Alzheimer's disease and other dementias. Annals of the New York Academy of Sciences. 826: 7-24. PMID 9329677 DOI: 10.1111/J.1749-6632.1997.Tb48457.X |
0.466 |
|
| 1997 |
Lambert JC, Pérez-Tur J, Dupire MJ, Galasko D, Mann D, Amouyel P, Hardy J, Delacourte A, Chartier-Harlin MC. Distortion of allelic expression of apolipoprotein E in Alzheimer's disease. Human Molecular Genetics. 6: 2151-4. PMID 9328480 DOI: 10.1093/Hmg/6.12.2151 |
0.371 |
|
| 1997 |
Buée-Scherrer V, Buée L, Leveugle B, Perl DP, Vermersch P, Hof PR, Delacourte A. Pathological tau proteins in postencephalitic parkinsonism: comparison with Alzheimer's disease and other neurodegenerative disorders. Annals of Neurology. 42: 356-9. PMID 9307257 DOI: 10.1002/Ana.410420312 |
0.515 |
|
| 1997 |
Tranchant C, Sergeant N, Wattez A, Mohr M, Warter JM, Delacourte A. Neurofibrillary tangles in Gerstmann-Sträussler-Scheinker syndrome with the A117V prion gene mutation. Journal of Neurology, Neurosurgery, and Psychiatry. 63: 240-6. PMID 9285466 DOI: 10.1136/Jnnp.63.2.240 |
0.431 |
|
| 1997 |
Sergeant N, David JP, Lefranc D, Vermersch P, Wattez A, Delacourte A. Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases. Febs Letters. 412: 578-82. PMID 9276470 DOI: 10.1016/S0014-5793(97)00859-4 |
0.543 |
|
| 1997 |
Sergeant N, David JP, Goedert M, Jakes R, Vermersch P, Buée L, Lefranc D, Wattez A, Delacourte A. Two-dimensional characterization of paired helical filament-tau from Alzheimer's disease: demonstration of an additional 74-kDa component and age-related biochemical modifications. Journal of Neurochemistry. 69: 834-44. PMID 9231745 DOI: 10.1046/J.1471-4159.1997.69020834.X |
0.538 |
|
| 1997 |
Wavrant-DeVrièze F, Pérez-Tur J, Lambert JC, Frigard B, Pasquier F, Delacourte A, Amouyel P, Hardy J, Chartier-Harlin MC. Association between the low density lipoprotein receptor-related protein (LRP) and Alzheimer's disease. Neuroscience Letters. 227: 68-70. PMID 9178861 DOI: 10.1016/S0304-3940(97)00304-2 |
0.427 |
|
| 1997 |
Delacourte A, Buée L. Normal and pathological Tau proteins as factors for microtubule assembly. International Review of Cytology. 171: 167-224. PMID 9066128 DOI: 10.1016/S0074-7696(08)62588-7 |
0.462 |
|
| 1997 |
Robitaille Y, Delacourte A, Sergeant N, Buée L, Veilleux F, Gauvreau D. PHENOTYPIC SUB-SETS OF LEWY BODY DEMENTIAS ARE BEST DEFINED BY DENSITIES AND NEUROANATOMICAL DISTRIBUTION OF HYPERPHOSPHORYLATED TAU ISOFORM TRIPLETS Journal of Neuropathology and Experimental Neurology. 56: 590. DOI: 10.1097/00005072-199705000-00089 |
0.364 |
|
| 1997 |
Caramelli P, Guevara J, Dilhuydy H, Joanette Y, Mena R, Nitrini R, Mourton-Gilles C, Delacourte A, Gauvreau D, Robitaille Y. 1-12-07 Bi-hemispheric neuropathological correlates of cognitive deficits in Alzheimer's disease Journal of the Neurological Sciences. 150: S18. DOI: 10.1016/S0022-510X(97)84907-6 |
0.356 |
|
| 1997 |
Delacourte A. Physiopathology of Alzheimer's disease | Physiopathologie de la maladie d'Alzheimer Medecine Therapeutique. 3: 369-376. |
0.324 |
|
| 1996 |
Caillet-Boudin ML, Delacourte A. Induction of a specific tau Alzheimer epitope in SY-5Y neuroblastoma cells. Neuroreport. 8: 307-10. PMID 9051801 |
0.368 |
|
| 1996 |
Lambert JC, Pérez-Tur J, Dupire MJ, Delacourte A, Frigard B, Chartier-Harlin MC. Analysis of the APOE alleles impact in Down's syndrome. Neuroscience Letters. 220: 57-60. PMID 8977148 DOI: 10.1016/S0304-3940(96)13244-4 |
0.437 |
|
| 1996 |
Buée Scherrer V, Hof PR, Buée L, Leveugle B, Vermersch P, Perl DP, Olanow CW, Delacourte A. Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick's disease. Acta Neuropathologica. 91: 351-9. PMID 8928611 DOI: 10.1007/S004010050436 |
0.53 |
|
| 1996 |
Buée L, Pérez-Tur J, Leveugle B, Buée-Scherrer V, Mufson EJ, Loerzel AJ, Chartier-Harlin MC, Perl DP, Delacourte A, Hof PR. Apolipoprotein E in Guamanian amyotrophic lateral sclerosis/parkinsonism-dementia complex: genotype analysis and relationships to neuropathological changes. Acta Neuropathologica. 91: 247-53. PMID 8834536 DOI: 10.1007/S004010050422 |
0.414 |
|
| 1996 |
Lefranc D, Vermersch P, Dallongeville J, Daems-Monpeurt C, Petit H, Delacourte A. Relevance of the quantification of apolipoprotein E in the cerebrospinal fluid in Alzheimer's disease. Neuroscience Letters. 212: 91-4. PMID 8832646 DOI: 10.1016/0304-3940(96)12774-9 |
0.375 |
|
| 1996 |
Buée-Scherrer V, Condamines O, Mourton-Gilles C, Jakes R, Goedert M, Pau B, Delacourte A. AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease. Brain Research. Molecular Brain Research. 39: 79-88. PMID 8804716 DOI: 10.1016/0169-328X(96)00003-4 |
0.544 |
|
| 1996 |
Vermersch P, Sergeant N, Ruchoux MM, Hofmann-Radvanyi H, Wattez A, Petit H, Dwailly P, Delacourte A. Specific tau variants in the brains of patients with myotonic dystrophy. Neurology. 47: 711-7. PMID 8797469 DOI: 10.1212/Wnl.47.3.711 |
0.528 |
|
| 1996 |
Delacourte A, Robitaille Y, Sergeant N, Buée L, Hof PR, Wattez A, Laroche-Cholette A, Mathieu J, Chagnon P, Gauvreau D. Specific pathological Tau protein variants characterize Pick's disease. Journal of Neuropathology and Experimental Neurology. 55: 159-68. PMID 8786374 DOI: 10.1097/00005072-199602000-00004 |
0.561 |
|
| 1996 |
Couratier P, Lesort M, Condamines O, Mourton-Gilles C, Delacourte A, Hugon J. Phorbol ester enhances phosphorylated tau protein immunoreactivity in neuronal cultures. Neuroscience Letters. 203: 155-8. PMID 8742016 DOI: 10.1016/0304-3940(96)12302-8 |
0.504 |
|
| 1996 |
Soulié C, Lépagnol J, Delacourte A, Caillet-Boudin ML. Dephosphorylation studies of SKNSH-SY 5Y cell Tau proteins by endogenous phosphatase activity. Neuroscience Letters. 206: 189-92. PMID 8710183 DOI: 10.1016/S0304-3940(96)12472-1 |
0.458 |
|
| 1996 |
Hof PR, Buée-Scherrer V, Buée L, Perl DP, Delacourte A. Immunohistochemical and Biochemical Characteristics of Tau Proteins in Neurodegenerative Disorders Journal of Neuropathology and Experimental Neurology. 55: 635. DOI: 10.1097/00005072-199605000-00130 |
0.399 |
|
| 1996 |
Gougat C, Pérachon S, Goedert M, Condamines O, Delacourte A, Pau B, Granier C, Mourton-Gilles C. 404 Molecular characterization of the epitopes of two anti PHF-Tau monoclonal antibodies used in an immunoassay for the mapping of neurofibrillary degeneration in Alzheimer's disease Neurobiology of Aging. 17: S101. DOI: 10.1016/S0197-4580(96)80406-4 |
0.421 |
|
| 1996 |
Delacourte A, Sergeant N, Buée-Scherrer V, Buée L, David J-, Bussière T, Vermersch P, Wattez A. 6 Pathological Tau proteins are biochemical markers that differentiate several types of neurofibrillary degeneration Neurobiology of Aging. 17. DOI: 10.1016/S0197-4580(96)80008-X |
0.431 |
|
| 1995 |
Pérez-Tur J, Campion D, Martinez M, Brice A, Tardieu S, Hannequin D, Agid Y, Delacourte A, Clerget-Darpoux F, Chartier-Harlin MC. Evidence for apolipoprotein E epsilon 4 association in early-onset Alzheimer's patients with late-onset relatives. American Journal of Medical Genetics. 60: 550-3. PMID 8825894 DOI: 10.1002/Ajmg.1320600613 |
0.365 |
|
| 1995 |
Sergeant N, Bussière T, Vermersch P, Lejeune JP, Delacourte A. Isoelectric point differentiates PHF-tau from biopsy-derived human brain tau proteins. Neuroreport. 6: 2217-20. PMID 8595206 DOI: 10.1097/00001756-199511000-00028 |
0.33 |
|
| 1995 |
Vermersch P, David JP, Frigard B, Fallet-Bianco C, Wattez A, Petit H, Delacourte A. Cortical mapping of Alzheimer pathology in brains of aged non-demented subjects. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 19: 1035-47. PMID 8584681 DOI: 10.1016/0278-5846(95)00195-6 |
0.496 |
|
| 1995 |
Reig S, Buée-Scherrer V, Mourton-Gilles C, Defossez A, Delacourte A, Beauvillain JC, Mazzuca M. Immunogold labelling of paired helical filaments and amyloid fibrils by specific monoclonal and polyclonal antibodies. Acta Neuropathologica. 90: 441-7. PMID 8560975 DOI: 10.1007/Bf00294803 |
0.467 |
|
| 1995 |
Dupont-Wallois L, Sautière PE, Cocquerelle C, Bailleul B, Delacourte A, Caillet-Boudin ML. Shift from fetal-type to Alzheimer-type phosphorylated Tau proteins in SKNSH-SY 5Y cells treated with okadaic acid. Febs Letters. 357: 197-201. PMID 7805890 DOI: 10.1016/0014-5793(94)01361-4 |
0.491 |
|
| 1995 |
Buée-Scherrer V, Buée L, Hof PR, Leveugle B, Gilles C, Loerzel AJ, Perl DP, Delacourte A. Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam. Immunochemical characterization of tau proteins. The American Journal of Pathology. 146: 924-32. PMID 7717459 |
0.335 |
|
| 1995 |
Condamines O, Buée-Scherrer V, Boissier L, Wattez A, Delacourte A, Pau B, Mourton-Gilles C. New immunoassay for the mapping of neurofibrillary degeneration in Alzheimer's disease using two monoclonal antibodies against human paired helical filament tau proteins. Neuroscience Letters. 192: 81-4. PMID 7675326 DOI: 10.1016/0304-3940(95)11617-6 |
0.51 |
|
| 1995 |
Vermersch P, Bordet R, Ledoze F, Ruchoux MM, Chapon F, Thomas P, Destée A, Lechevallier B, Delacourte A. [Demonstration of a specific profile of pathological Tau proteins in frontotemporal dementia cases]. Comptes Rendus De L'Acadã©Mie Des Sciences. Sã©Rie Iii, Sciences De La Vie. 318: 439-45. PMID 7648357 |
0.348 |
|
| 1995 |
Buée L, Permanne B, Pérez-Tur J, Chartier-Harlin MC, Delacourte A. Alzheimer's disease: A beta or ApoE amyloidosis? Lancet. 346: 59. PMID 7603172 DOI: 10.1016/S0140-6736(95)92694-1 |
0.394 |
|
| 1995 |
Permanne B, Buée L, David JP, Fallet-Bianco C, Di Menza C, Delacourte A. Quantitation of Alzheimer's amyloid peptide and identification of related amyloid proteins by dot-blot immunoassay. Brain Research. 685: 154-62. PMID 7583241 DOI: 10.1016/0006-8993(95)00431-O |
0.408 |
|
| 1994 |
Vermersch P, Robitaille Y, Bernier L, Wattez A, Gauvreau D, Delacourte A. Biochemical mapping of neurofibrillary degeneration in a case of progressive supranuclear palsy: evidence for general cortical involvement. Acta Neuropathologica. 87: 572-7. PMID 8091949 DOI: 10.1007/BF00293317 |
0.404 |
|
| 1994 |
Buée L, Hof PR, Bouras C, Delacourte A, Perl DP, Morrison JH, Fillit HM. Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders. Acta Neuropathologica. 87: 469-80. PMID 8059599 DOI: 10.1007/Bf00294173 |
0.392 |
|
| 1994 |
Giannakopoulos P, Hof PR, Giannakopoulos AS, Buée-Scherrer V, Surini M, Delacourte A, Bouras C. Dementia in the oldest-old: quantitative analysis of 12 cases from a psychiatric hospital. Dementia (Basel, Switzerland). 5: 348-56. PMID 7866489 DOI: 10.1159/000106745 |
0.409 |
|
| 1994 |
Delacourte A. Pathological Tau proteins of Alzheimer's disease as a biochemical marker of neurofibrillary degeneration. Biomedicine & Pharmacotherapy = Biomã©Decine & Pharmacothã©Rapie. 48: 287-95. PMID 7858159 DOI: 10.1016/0753-3322(94)90174-0 |
0.436 |
|
| 1994 |
Hof PR, Nimchinsky EA, Buée-Scherrer V, Buée L, Nasrallah J, Hottinger AF, Purohit DP, Loerzel AJ, Steele JC, Delacourte A. Amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam: quantitative neuropathology, immunohistochemical analysis of neuronal vulnerability, and comparison with related neurodegenerative disorders. Acta Neuropathologica. 88: 397-404. PMID 7847067 DOI: 10.1007/Bf00389490 |
0.483 |
|
| 1994 |
Vickers JC, Riederer BM, Marugg RA, Buée-Scherrer V, Buée L, Delacourte A, Morrison JH. Alterations in neurofilament protein immunoreactivity in human hippocampal neurons related to normal aging and Alzheimer's disease. Neuroscience. 62: 1-13. PMID 7816192 DOI: 10.1016/0306-4522(94)90310-7 |
0.466 |
|
| 1993 |
Vermersch P, Sautière PE, Goudemand M, Delacourte A. General cortical involvement in a late-onset case of Alzheimer disease. A biochemical approach by quantitation of abnormal tau proteins. Molecular and Chemical Neuropathology / Sponsored by the International Society For Neurochemistry and the World Federation of Neurology and Research Groups On Neurochemistry and Cerebrospinal Fluid. 18: 213-24. PMID 8507301 DOI: 10.1007/Bf03160115 |
0.503 |
|
| 1993 |
Vermersch P, Delacourte A, Javoy-Agid F, Hauw JJ, Agid Y. Dementia in Parkinson's disease: biochemical evidence for cortical involvement using the immunodetection of abnormal Tau proteins. Annals of Neurology. 33: 445-50. PMID 8498822 DOI: 10.1002/Ana.410330506 |
0.438 |
|
| 1993 |
Buée L, Ding W, Delacourte A, Fillit H. Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide. Brain Research. 601: 154-63. PMID 8431762 DOI: 10.1016/0006-8993(93)91706-X |
0.419 |
|
| 1993 |
Carette B, Poulain P, Delacourte A. Electrophysiological effects of 25-35 amyloid-beta-protein on guinea-pig lateral septal neurons. Neuroscience Letters. 151: 111-4. PMID 8385758 DOI: 10.1016/0304-3940(93)90059-T |
0.387 |
|
| 1993 |
Buée L, Ding W, Anderson JP, Narindrasorasak S, Kisilevsky R, Boyle NJ, Robakis NK, Delacourte A, Greenberg B, Fillit HM. Binding of vascular heparan sulfate proteoglycan to Alzheimer's amyloid precursor protein is mediated in part by the N-terminal region of A4 peptide. Brain Research. 627: 199-204. PMID 8298962 DOI: 10.1016/0006-8993(93)90321-D |
0.409 |
|
| 1993 |
Delacourte A. [Physiopathological bases of Alzheimer disease]. Thã©Rapie. 48: 177-83. PMID 8140554 |
0.312 |
|
| 1993 |
Sautière PE, Caillet-Boudin ML, Wattez A, Buée-Scherrer V, Delacourte A. [Detection of Alzheimer type pathological epitopes on Tau proteins of neuroblastoma cells after treatment with okadaic acid]. Comptes Rendus De L'Acadã©Mie Des Sciences. Sã©Rie Iii, Sciences De La Vie. 316: 533-5. PMID 7693312 |
0.328 |
|
| 1992 |
Lucas C, Parent M, Delandsheer E, Delacourte A, Fournier Y, Défossez A, Leys D. [Multiple cerebral hemorrhage and amyloid angiopathy of the white matter in a case of Alzheimer's disease]. Revue Neurologique. 148: 218-20. PMID 1604138 |
0.304 |
|
| 1992 |
Crawford F, Chartier-Harlin MC, Mullan M, Hardy J, Delacourte A, Arnott G. Alzheimer's--a correction. Nature. 356: 390. PMID 1557118 DOI: 10.1038/356390B0 |
0.406 |
|
| 1992 |
Hof PR, Bierer LM, Perl DP, Delacourte A, Buée L, Bouras C, Morrison JH. Evidence for early vulnerability of the medial and inferior aspects of the temporal lobe in an 82-year-old patient with preclinical signs of dementia. Regional and laminar distribution of neurofibrillary tangles and senile plaques. Archives of Neurology. 49: 946-53. PMID 1520086 DOI: 10.1001/Archneur.1992.00530330070019 |
0.453 |
|
| 1992 |
Hof PR, Delacourte A, Bouras C. Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: a quantitative analysis of six cases. Acta Neuropathologica. 84: 45-51. PMID 1502881 DOI: 10.1007/Bf00427214 |
0.354 |
|
| 1992 |
Vickers JC, Delacourte A, Morrison JH. Progressive transformation of the cytoskeleton associated with normal aging and Alzheimer's disease. Brain Research. 594: 273-8. PMID 1450952 DOI: 10.1016/0006-8993(92)91134-Z |
0.429 |
|
| 1992 |
Vermersch P, Frigard B, David JP, Fallet-Bianco C, Delacourte A. Presence of abnormally phosphorylated Tau proteins in the entorhinal cortex of aged non-demented subjects. Neuroscience Letters. 144: 143-6. PMID 1436694 DOI: 10.1016/0304-3940(92)90736-Q |
0.41 |
|
| 1992 |
Buée L, Hof PR, Roberts DD, Delacourte A, Morrison JH, Fillit HM. Immunohistochemical identification of thrombospondin in normal human brain and in Alzheimer's disease. The American Journal of Pathology. 141: 783-8. PMID 1415477 |
0.377 |
|
| 1992 |
Hof PR, Charpiot A, Delacourte A, Buée L, Purohit D, Perl DP, Bouras C. Distribution of neurofibrillary tangles and senile plaques in the cerebral cortex in postencephalitic parkinsonism. Neuroscience Letters. 139: 10-4. PMID 1407674 DOI: 10.1016/0304-3940(92)90846-Y |
0.391 |
|
| 1992 |
Vallet PG, Guntern R, Hof PR, Golaz J, Delacourte A, Robakis NK, Bouras C. A comparative study of histological and immunohistochemical methods for neurofibrillary tangles and senile plaques in Alzheimer's disease. Acta Neuropathologica. 83: 170-8. PMID 1373017 DOI: 10.1007/Bf00308476 |
0.455 |
|
| 1992 |
Sautière PE, Sindou P, Couratier P, Hugon J, Wattez A, Delacourte A. Tau antigenic changes induced by glutamate in rat primary culture model: a biochemical approach. Neuroscience Letters. 140: 206-10. PMID 1354342 DOI: 10.1016/0304-3940(92)90104-F |
0.446 |
|
| 1992 |
Vermersch P, Frigard B, Delacourte A. Mapping of neurofibrillary degeneration in Alzheimer's disease: evaluation of heterogeneity using the quantification of abnormal tau proteins. Acta Neuropathologica. 85: 48-54. PMID 1285496 DOI: 10.1007/Bf00304633 |
0.479 |
|
| 1992 |
Hof PR, Bouras C, Buée L, Delacourte A, Perl DP, Morrison JH. Differential distribution of neurofibrillary tangles in the cerebral cortex of dementia pugilistica and Alzheimer's disease cases. Acta Neuropathologica. 85: 23-30. PMID 1285493 DOI: 10.1007/Bf00304630 |
0.494 |
|
| 1992 |
Sautière PE, Sindou P, Couratier P, Hugon J, Wattez A, Delacourte A. The effects of glutamate on tau immunoreactivity in rat primary neuronal culture Neurobiology of Aging. 13. DOI: 10.1016/0197-4580(92)90531-2 |
0.305 |
|
| 1992 |
Sindou P, Sautiere PE, Couratier P, Delacourte A, Hugon J. Immunocytochemical characterization of experimental Tau protein accumulation Neurobiology of Aging. 13. DOI: 10.1016/0197-4580(92)90529-7 |
0.428 |
|
| 1992 |
Bouras C, Giannakopoulos P, Hof P, Robakis N, Delacourte A, Surini M, Michel J. Neuropathological study of 21 centenarians Neurobiology of Aging. 13: S39. DOI: 10.1016/0197-4580(92)90280-B |
0.372 |
|
| 1991 |
Ceballos I, Javoy-Agid F, Delacourte A, Defossez A, Lafon M, Hirsch E, Nicole A, Sinet PM, Agid Y. Neuronal localization of copper-zinc superoxide dismutase protein and mRNA within the human hippocampus from control and Alzheimer's disease brains. Free Radical Research Communications. 12: 571-80. PMID 2060834 DOI: 10.3109/10715769109145832 |
0.326 |
|
| 1991 |
Leys D, Pruvo JP, Parent M, Vermersch P, Soetaert G, Steinling M, Delacourte A, Défossez A, Rapoport A, Clarisse J. Could Wallerian degeneration contribute to "leuko-araiosis" in subjects free of any vascular disorder? Journal of Neurology, Neurosurgery, and Psychiatry. 54: 46-50. PMID 2010759 DOI: 10.1136/Jnnp.54.1.46 |
0.437 |
|
| 1991 |
Flament S, Delacourte A, Verny M, Hauw JJ, Javoy-Agid F. Abnormal Tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type. Acta Neuropathologica. 81: 591-6. PMID 1831952 DOI: 10.1007/Bf00296367 |
0.538 |
|
| 1991 |
Behrouz N, Defossez A, Delacourte A, Mazzuca M. The immunohistochemical evidence of amyloid diffuse deposits as a pathological hallmark in Alzheimer's disease. Journal of Gerontology. 46: B209-12. PMID 1719062 DOI: 10.1093/Geronj/46.6.B209 |
0.46 |
|
| 1991 |
Ceballos-Picot I, Nicole A, Briand P, Grimber G, Delacourte A, Defossez A, Javoy-Agid F, Lafon M, Blouin JL, Sinet PM. Neuronal-specific expression of human copper-zinc superoxide dismutase gene in transgenic mice: animal model of gene dosage effects in Down's syndrome. Brain Research. 552: 198-214. PMID 1717112 DOI: 10.1016/0006-8993(91)90084-9 |
0.344 |
|
| 1990 |
Delacourte A. General and dramatic glial reaction in Alzheimer brains. Neurology. 40: 33-7. PMID 2296379 DOI: 10.1212/Wnl.40.1.33 |
0.417 |
|
| 1990 |
Flament S, Delacourte A, Mann DM. Phosphorylation of Tau proteins: a major event during the process of neurofibrillary degeneration. A comparative study between Alzheimer's disease and Down's syndrome. Brain Research. 516: 15-9. PMID 2142011 DOI: 10.1016/0006-8993(90)90891-E |
0.537 |
|
| 1990 |
Flament S, Delacourte A, Delaère P, Duyckaerts C, Hauw JJ. Correlation between microscopical changes and Tau 64 and 69 biochemical detection in senile dementia of the Alzheimer type. Tau 64 and 69 are reliable markers of the neurofibrillary degeneration. Acta Neuropathologica. 80: 212-5. PMID 2117842 DOI: 10.1007/Bf00308927 |
0.51 |
|
| 1990 |
Delacourte A, Flament S, Dibe EM, Hublau P, Sablonnière B, Hémon B, Shérrer V, Défossez A. Pathological proteins Tau 64 and 69 are specifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer's disease. Demonstration with a panel of antibodies against Tau proteins. Acta Neuropathologica. 80: 111-7. PMID 2117840 DOI: 10.1007/Bf00308912 |
0.522 |
|
| 1990 |
Flament S, Delacourte A. Tau marker? Nature. 346: 22. PMID 2114549 DOI: 10.1038/346022a0 |
0.312 |
|
| 1990 |
Behrouz N, Defossez A, Delacourte A, Mazzuca M. What role may microglial cells play in plaque formation in Alzheimer's disease Neurobiology of Aging. 11: 311. DOI: 10.1016/0197-4580(90)90796-3 |
0.422 |
|
| 1990 |
Delacourte A, Flament S, Défossez A. Towards the development of an in vitro study model of Alzheimer-type neurofibrillary degeneration Neurobiology of Aging. 11: 279-280. DOI: 10.1016/0197-4580(90)90665-M |
0.383 |
|
| 1989 |
Rosemblatt M, Fellous A, Mazie JC, Delacourte A, Defossez A. Alzheimer's disease: microtubule-associated proteins 2 (MAP 2) are not components of paired helical filaments. Febs Letters. 252: 91-4. PMID 2759234 |
0.308 |
|
| 1989 |
Behrouz N, Defossez A, Delacourte A, Hublau P, Mazzuca M. An antiserum to the N-terminal subsequence of the Alzheimer amyloid beta protein does not react with neurofibrillary tangles. Journal of Gerontology. 44: B156-9. PMID 2681356 DOI: 10.1093/Geronj/44.6.B156 |
0.41 |
|
| 1989 |
Mann DM, Prinja D, Davies CA, Ihara Y, Delacourte A, Défossez A, Mayer RJ, Landon M. Immunocytochemical profile of neurofibrillary tangles in Down's syndrome patients of different ages. Journal of the Neurological Sciences. 92: 247-60. PMID 2553874 DOI: 10.1016/0022-510X(89)90140-8 |
0.46 |
|
| 1989 |
Behrouz N, Defossez A, Delacourte A, Hublau P, Mazzuca M. [Alzheimer's disease: immunohistochemical characterization of cerebral amyloid deposits]. Comptes Rendus De L'Acadã©Mie Des Sciences. Sã©Rie Iii, Sciences De La Vie. 308: 437-44. PMID 2543486 |
0.352 |
|
| 1989 |
Lenders MB, Peers MC, Tramu G, Delacourte A, Defossez A, Petit H, Mazzuca M. Dystrophic neuropeptidergic neurites in senile plaques of Alzheimer's disease precede formation of paired helical filaments. Acta Neurologica Belgica. 89: 279-85. PMID 2516978 |
0.381 |
|
| 1989 |
Delacourte A, Flament S, Behrouz N, Defossez A. [Alzheimer's disease: tau microtubular protein and beta protein A4 constitute 2 different types of amyloid substance]. Acta Neurologica Belgica. 89: 274-5. PMID 2516977 |
0.345 |
|
| 1989 |
Buee L, Laine A, Delacourte A, Flament S, Han KK. Qualitative and quantitative comparison of brain proteins in Alzheimer's disease. Biological Chemistry Hoppe-Seyler. 370: 1229-34. PMID 2514723 DOI: 10.1515/Bchm3.1989.370.2.1229 |
0.45 |
|
| 1989 |
Flament S, Delacourte A, Hémon B, Défossez A. Characterization of two pathological tau protein, variants in Alzheimer brain cortices. Journal of the Neurological Sciences. 92: 133-41. PMID 2509637 DOI: 10.1016/0022-510X(89)90131-7 |
0.549 |
|
| 1989 |
Lenders MB, Peers MC, Tramu G, Delacourte A, Defossez A, Petit H, Mazzuca M. Dystrophic peptidergic neurites in senile plaques of Alzheimer's disease hippocampus precede formation of paired helical filaments. Brain Research. 481: 344-9. PMID 2497927 DOI: 10.1016/0006-8993(89)90812-3 |
0.451 |
|
| 1989 |
Flament S, Delacourte A. Abnormal tau species are produced during Alzheimer's disease neurodegenerating process. Febs Letters. 247: 213-6. PMID 2497028 DOI: 10.1016/0014-5793(89)81337-7 |
0.522 |
|
| 1989 |
Flament S, Delacourte A, Hemon B, Defossez A. [Direct demonstration of abnormal phosphorylation of Tau microtubular proteins in Alzheimer's disease]. Comptes Rendus De L'Acadã©Mie Des Sciences. Sã©Rie Iii, Sciences De La Vie. 308: 77-82. PMID 2493316 |
0.419 |
|
| 1989 |
Behrouz N, Defossez A, Delacourte A, Hublau P, Mazzuca M. Alzheimer's disease: glycolytic pretreatment dramatically enhances immunolabeling of senile plaques and cerebrovascular amyloid substance. Laboratory Investigation; a Journal of Technical Methods and Pathology. 61: 576-83. PMID 2478759 |
0.38 |
|
| 1988 |
Amouyel P, Gégonne A, Delacourte A, Défossez A, Stéhelin D. Expression of ETS proto-oncogenes in astrocytes in human cortex. Brain Research. 447: 149-53. PMID 3289683 DOI: 10.1016/0006-8993(88)90976-6 |
0.383 |
|
| 1988 |
Delacourte A, Defossez A, Ceballos I, Nicole A, Sinet PM. Preferential localization of copper zinc superoxide dismutase in the vulnerable cortical neurons in Alzheimer's disease. Neuroscience Letters. 92: 247-53. PMID 3200483 DOI: 10.1016/0304-3940(88)90597-6 |
0.436 |
|
| 1988 |
Peers MC, Lenders MB, Défossez A, Delacourte A, Mazzuca M. Cortical angiopathy in Alzheimer's disease: the formation of dystrophic perivascular neurites is related to the exudation of amyloid fibrils from the pathological vessels. Virchows Archiv. a, Pathological Anatomy and Histopathology. 414: 15-20. PMID 3144799 DOI: 10.1007/Bf00749733 |
0.484 |
|
| 1988 |
Parent M, Delacourte A, Défossez A, Hémon B, Han KK, Petit H. [Alzheimer's disease: study of the distribution of tau proteins constituting helical filament pairs in human central nervous tissue]. Comptes Rendus De L'Acadã©Mie Des Sciences. Sã©Rie Iii, Sciences De La Vie. 306: 391-7. PMID 3136867 |
0.365 |
|
| 1988 |
Defossez A, Beauvillain JC, Delacourte A, Mazzuca M. Alzheimer's disease: a new evidence for common epitopes between microtubule associated protein Tau and paired helical filaments (PHF): demonstration at the electron microscope level by a double immunogold labelling. Virchows Archiv. a, Pathological Anatomy and Histopathology. 413: 141-5. PMID 2455379 DOI: 10.1007/Bf00749675 |
0.51 |
|
| 1987 |
Defossez A, el Hachimi K, Beauvillain JC, Perre J, Delacourte A, Foncin JF. [Immunocytochemical study at the ultrastructural level of neurofibrillary degeneration in Alzheimer's disease]. Comptes Rendus De L'Acadã©Mie Des Sciences. Sã©Rie Iii, Sciences De La Vie. 304: 217-22. PMID 3102001 |
0.38 |
|
| 1987 |
Défossez A, Delacourte A. Transformation of degenerating neurofibrils into amyloid substance in Alzheimer's disease: histochemical and immunohistochemical studies. Journal of the Neurological Sciences. 81: 1-10. PMID 2445923 DOI: 10.1016/0022-510X(87)90179-1 |
0.482 |
|
| 1987 |
Delacourte A, Defossez A, Persuy P, Peers MC. Observation of morphological relationships between angiopathic blood vessels and degenerative neurites in Alzheimer's disease. Virchows Archiv. a, Pathological Anatomy and Histopathology. 411: 199-204. PMID 2441514 DOI: 10.1007/Bf00735024 |
0.437 |
|
| 1986 |
Delacourte A, Defossez A. Alzheimer's disease: Tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments. Journal of the Neurological Sciences. 76: 173-86. PMID 3098926 DOI: 10.1097/00002093-198701030-00024 |
0.462 |
|
| 1985 |
Persuy P, Defossez A, Delacourte A, Tramu G, Bouchez B, Arnott G. Anti-PHF antibodies: an immunohistochemical marker of the lesions of the Alzheimer's disease. Characterization and comparison with Bodian's silver impregnation. Virchows Archiv. a, Pathological Anatomy and Histopathology. 407: 13-23. PMID 2409667 DOI: 10.1007/Bf00701325 |
0.394 |
|
| 1977 |
Delacourte A, Plancot MT, Boutteau F, Han KK, Hildebrand HF, Biserte G. [Preparation of highly purified microbules and evidence for a novel molecular arrangement at low temperatures]. Biochimie. 59: 479-86. PMID 889933 DOI: 10.1016/S0300-9084(77)80053-9 |
0.335 |
|
| Show low-probability matches. |
